Metastatic Prostate Carcinoma in the Soft Tissue: 113 Clinical Trials, Page 2 of 12

A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)

Condition(s):Prostate Carcinoma Metastatic to the Bone; Castration Resistant Prostate CancerLast Updated:May 5, 2020Completed

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Condition(s):Prostatic NeoplasmsLast Updated:July 12, 2019Completed

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Condition(s):Prostate Cancer MetastaticLast Updated:December 14, 2015Completed

A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Condition(s):Prostatic NeoplasmsLast Updated:August 14, 2019Completed

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

Condition(s):Prostate CancerLast Updated:February 26, 2020Active, not recruiting

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Condition(s):Metastatic Prostate CancerLast Updated:June 26, 2020Recruiting

11C or 18F-Choline PET/CT and Whole Body MRI for Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide

Condition(s):Prostate Cancer MetastaticLast Updated:February 18, 2020Active, not recruiting

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Condition(s):Castration Resistant Metastatic Prostate CancerLast Updated:July 14, 2020Not yet recruiting

Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

Condition(s):Prostate Cancer MetastaticLast Updated:November 8, 2019Active, not recruiting

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Condition(s):Prostate Cancer MetastaticLast Updated:December 12, 2017Terminated

«1 2 3 4 5 …10 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.